C
Curis D
D
CRIS
1.97000
USD
-0.01
(-0.51%)
مغلق
حجم التداول
591
الربح لكل سهم
-5
العائد الربحي
-
P/E
-0
حجم السوق
20,610,633
الأخبار المقالات
العنوان: Curis
القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.